Human ADCYAP1 (Pituitary adenylate cyclase-activating polypeptide) ELISA Kit

Este producto es parte de ADCYAP1 - adenylate cyclase activating polypeptide 1 ( RECEPTOR)
Human ADCYAP1 (Pituitary adenylate cyclase-activating polypeptide) ELISA Kit
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human ADCYAP1 (Pituitary adenylate cyclase-activating polypeptide) ELISA Kit
Category
ELISA Kits
Provider
FineTest
Reference
EH1515
Tested Applications
ELISA

Documentos del producto

Instrucciones
Descargar
Data sheet

Especificaciones del producto

Category
ELISA Kits
Reactivity
Human
Detection Method
Colorimetric
Assay Data
4 hours
Assay Type
Sandwich ELISA, Double Antibody
Test Range
7.813-500pg/ml
Sensitivity
4.688pg/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
UniProt ID
P18509
Alias
PACAP
Background
Elisa kits for ADCYAP1
Status
RUO

Background

Adenylate Cyclase Activating Polypeptide 1 (ADCYAP1) is a neuropeptide that acts as a ligand for its receptor, ADCYAP1 receptor. It plays crucial roles in regulating various physiological processes, including neurotransmission, neuroprotection, and modulation of the stress response. The ADCYAP1 receptor, also known as PAC1 receptor, is widely distributed throughout the central nervous system and peripheral tissues, indicating its diverse functions. Upon binding of ADCYAP1 to its receptor, intracellular signaling pathways are activated, leading to the production of cyclic adenosine monophosphate (cAMP) and subsequent activation of protein kinase A (PKA) and other downstream effectors. This signaling cascade influences synaptic transmission, neuronal excitability, and cellular responses to stressors. Dysregulation of ADCYAP1 signaling has been implicated in various neurological and psychiatric disorders, including anxiety, depression, and neurodegenerative diseases. Understanding the mechanisms underlying ADCYAP1 receptor activation provides insights into its physiological functions and potential therapeutic targets for neurological and psychiatric disorders. Ongoing research aims to elucidate the roles of ADCYAP1 signaling in health and disease, paving the way for the development of novel treatment strategies.

Productos relacionados

abx032583

Pituitary Adenylate Cyclase-Activating Polypeptide / PACAP (ADCYAP1) Antibody

ADCYAP1 is adenylate cyclase activating polypeptide 1. Mediated by adenylate cyclase activating polypeptide 1 receptors,…

Ver producto
abx065164

Mouse Pituitary Adenylate Cyclase-Activating Polypeptide / PACAP (ADCYAP1) Protein

Mouse Pituitary Adenylate Cyclase-Activating Polypeptide / PACAP (ADCYAP1) is a recombinant Mouse protein expressed in E…

Ver producto
abx104654

Pituitary Adenylate Cyclase-Activating Polypeptide / PACAP (ADCYAP1) Antibody

Polyclonal Antibody to Pituitary Adenylate Cyclase-Activating Polypeptide / PACAP (ADCYAP1).…

Ver producto